Free NEWS Letter
The Sugar Trehalose
Affiliate Program
Untitled Document
Book Store
Store Front
Support The Endowment
Enter Amount:
We Accept
VisaMaster CardAmerican ExpressDiscoverssl lock
Main Menu
Home
- - - - - - -
Inside the Human Cell
The Sugar Trehalose
- - - - - - -
Sugar Science Forum
Glycomics Training
Interactive Glycomics Brochure
NEWS
7 FREE NEWSletters
HOT Links of Interest
- - - - - - -
Contact Us
Disclaimer
Sitemap
Evaluation Forms

Huntington’s General
Health Evaluation
FORM for Trehalose
Nutritional Pilot Survey

Parkinson's General
Health Evaluation
FORM for Trehalose
Nutritional Pilot Survey

Alzheimer / Dementia
General Health Evaluation
FORM for Trehalose
Nutritional Pilot Survey

Diabetic Health Evaluation
FORM for Trehalose
Nutritional Pilot Survey

General Public Health
Evaluation FORM for
Trehalose Nutritional
Pilot Survey (For General
Public without Huntington’s,
Alzheimer’s, or Parkinson’s.)

Chapter One
Chapter One

Chapter One

FREE Sneek Peek
Chapter One


Meet J.C. Spencer
"Glycomics II"
Replay 30 minute Conference call from July 3rd, 2008

"Glycomics"
Replay 30 minute Conference call from June 5th, 2008

"Trehalose and
Huntington's Disease
"
Replay 30 minute Conference call from May 8th, 2008
Who's Online
We have 16 guests online
Cause of deadly skin disease found to be in the genes
Harlequin ichthyosis (HI) is a severe skin disease that is usually lethal in newborns.

A dense scale that covers the skin, with abnormal facial features, characterizes it.
 
 The cause of HI was previously unknown. In a new study appearing in the July 1 print issue of The Journal of Clinical Investigation, Masashi Akiyama and colleagues from Hokkaido University report that mutations in a protein called ABCA12 are responsible for HI.
 
 In this study, the authors show that ABCA12 is a lipid transporter in skin cells. They identify 5 mutations in 4 HI families.
 
 In an accompanying commentary, Alain Hovnanian writes, "these results should allow for early prenatal diagnosis of HI and lend hope to the possibility of a specific treatment for this devastating disorder."
 
 Stacie Bloom
 press_releases@the-jci.org
 212-342-4159
 Journal of Clinical Investigation
 http://www.jci.org  

Source